Stanisic, S., Cicchetti, A., Porta, C., Procopio, G. and Berto, P. (2018) “Cost-effectiveness of cabozantinib in second-line treatment of metastatic renal cell cancer (mRCC) in Italy”, Global and Regional Health Technology Assessment, 5(1). doi: 10.33393/grhta.2018.434.